- Trials with a EudraCT protocol (22)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
22 result(s) found for: Intraoperative MRI.
Displaying page 1 of 2.
EudraCT Number: 2010-022057-42 | Sponsor Protocol Number: 3D-iUS-NCH | Start Date*: 2011-03-22 | |||||||||||
Sponsor Name:Universität Leipzig | |||||||||||||
Full Title: Pilot study to optimise the use and to evaluate the diagnostic value of intraoperative contrast-enhanced 3D-ultrasound with SonoVue® for imaging of intracranial tumors | |||||||||||||
Medical condition: Patients with an intracranial tumor and planned operation as well as expected echoic behaviour of the tumor | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003230-32 | Sponsor Protocol Number: 5-ALA_Meningiomas | Start Date*: 2015-11-17 |
Sponsor Name:Medizinische Universität Graz | ||
Full Title: The use of 5-aminolevulinic acid (gliolan) mediated protoporphyrin IX fluorescence to label neighbouring infiltration zones in meningiomas | ||
Medical condition: Surgical candidates with supratentorial meningiomas | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-003167-38 | Sponsor Protocol Number: NL50643.09r.r4 | Start Date*: 2015-04-28 |
Sponsor Name:Radboudumc | ||
Full Title: 68Ga-NODAGA-exendin-4 PET/CT in patients with AHH - a prospective comparative evaluation of preoperative imaging Under the FP7 project Betacure (602812); Personalized diagnosis and treatment of hy... | ||
Medical condition: Adult endogenous hyperinsulinemic hypoglycemia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005215-46 | Sponsor Protocol Number: VS_Nimodipine | Start Date*: 2021-02-19 |
Sponsor Name:Department of Neurosurgery, Medical University of Vienna | ||
Full Title: Intraoperative application of nimodipine to the facial and cochlear nerves during vestibular schwannoma resection to avoid spasm-related postoperative facial paralysis and deafness - a prospective ... | ||
Medical condition: Patients with vestibularis schwanomma undergoing microsurgical resection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005144-14 | Sponsor Protocol Number: 01-CARDIONIDO | Start Date*: 2018-04-12 |
Sponsor Name:Dr. Forteza Gil | ||
Full Title: Comparative study of two types of cardioplegia during cardiac surgery in the adult patient | ||
Medical condition: Cardiac surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-016501-41 | Sponsor Protocol Number: 400-09-001 | Start Date*: 2010-06-29 |
Sponsor Name:Omrix Biopharmaceuticals Ltd | ||
Full Title: A Randomized, Controlled Study to Evaluate the Safety and Effectiveness of Evicel as an Adjunct to Sutured Dural Repair | ||
Medical condition: tissue adhesion/sealing and suture support in neurosurgery and surgical procedures where contact with cerebrospinal fluid or dura mater can occur e.g. otologic, rhinologic, ophthalmic and vertebral... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) BE (Completed) NL (Completed) FI (Completed) GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-005838-19 | Sponsor Protocol Number: 2011.697 | Start Date*: 2012-12-28 | |||||||||||
Sponsor Name:Hospics Civils de Lyon | |||||||||||||
Full Title: MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF THE RESECTION OF GLIOBLASTOMAS - THE RESECT STUDY | |||||||||||||
Medical condition: Glioblastoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004796-40 | Sponsor Protocol Number: 2018_58 | Start Date*: 2020-06-11 |
Sponsor Name:CHU de Lille | ||
Full Title: Multicenter Phase II study with dose-light escalation, intraoperative glioblastoma photodynamic therapy | ||
Medical condition: Glioblastoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) BE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001732-38 | Sponsor Protocol Number: 1502 | Start Date*: 2015-09-14 | |||||||||||
Sponsor Name:CENTRE OSCAR LAMBRET | |||||||||||||
Full Title: EVALUATION OF SENTINEL NODE (SN) POLICY IN EARLY STAGE ENDOMETRIAL CARCINOMAS AT INTERMEDIATE AND HIGH RISK OF RECURRENCE: RANDOMIZED STUDY COMPARING SENTINEL NODE POLICY TO CURRENT FRENCH INITIAL ... | |||||||||||||
Medical condition: Intermediate-risk endometrioïd carcinomas : IAg3, IB(II)g1-2 High-risk endometrioïd carcinomas : IB-II g3 High-risk non endometrioïd carcinomas : I-II | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-004987-91 | Sponsor Protocol Number: 2020/ABM/01/00098 | Start Date*: 2021-11-17 | |||||||||||
Sponsor Name:Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu | |||||||||||||
Full Title: Effects of calcium electroporation, electrochemotherapy, and irreversible electroporation (IRE-CaCl2, ECT and IRE) on quality of life and progression – free survival in patients with pancreatic can... | |||||||||||||
Medical condition: Unresectable pancreatic cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002317-19 | Sponsor Protocol Number: KKSH155 | Start Date*: 2020-04-17 | |||||||||||
Sponsor Name:Martin-Luther-Universität Halle-Wittenberg | |||||||||||||
Full Title: Prophylactic nimodipine treatment for hearing preservation after vestibular schwannoma surgery: a randomized multi-center phase III trial | |||||||||||||
Medical condition: Vestibular schwannomas with indication for surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003068-28 | Sponsor Protocol Number: 77946 | Start Date*: 2021-09-29 | |||||||||||||||||||||
Sponsor Name:University Medical Center Utrecht | |||||||||||||||||||||||
Full Title: Sentinel lymph node detection of cervical occult lymph node metastases in patients with parotid gland carcinoma by means of sentinel node biopsy using 68-galium-tilmanocept PET-CT. | |||||||||||||||||||||||
Medical condition: The IMP will be used for the identification of sentinel lymph node(s) in patients with parotid gland carcinoma. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003832-35 | Sponsor Protocol Number: HIPEC/FLOT9 | Start Date*: 2020-07-27 | |||||||||||
Sponsor Name:Institute of Clinical Cancer Research (IKF) Krankenhaus Nordwest | |||||||||||||
Full Title: Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction Type II/III adenocarcinoma – The phase III “PREVENT” tri... | |||||||||||||
Medical condition: locally advanced resectable diffuse type adenocarcinoma of the oesophagogastric junction or the stomach | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001431-31 | Sponsor Protocol Number: EMR700692-007 | Start Date*: 2013-05-02 | |||||||||||
Sponsor Name:Merck KGaA | |||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, Phase II trial to investigate the efficacy and safety of 30 mcg and 100 mcg AS902330 given as one cycle of three intra-a... | |||||||||||||
Medical condition: Knee Cartilage Injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004449-35 | Sponsor Protocol Number: 80-86600-98-19047 | Start Date*: 2021-05-06 |
Sponsor Name:ZonMw | ||
Full Title: Antibiotic treatment following surgical drainage of perianal abscess: a double-blind, placebo-controlled, randomized trial | ||
Medical condition: Perianal fistula | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005604-54 | Sponsor Protocol Number: NXL104/2002 | Start Date*: 2009-04-10 | ||||||||||||||||
Sponsor Name:Novexel, S.A. | ||||||||||||||||||
Full Title: A prospective, multicentre, double-blind, randomized, comparative study to estimate the safety, tolerability and efficacy of NXL104/ceftazidime plus metronidazole vs. meropenem in the treatment of ... | ||||||||||||||||||
Medical condition: Complicated intra-abdominal infections (cIAI) in hospitalised adults | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BG (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001087-36 | Sponsor Protocol Number: Bay43-9006/12414 | Start Date*: 2008-08-18 | |||||||||||
Sponsor Name:Bayer Healthcare AG | |||||||||||||
Full Title: A Phase III randomized, double-blind, placebo-controlled study of sorafenib as adjuvant treatment for hepatocellular carcinoma after surgical resection or local ablation. | |||||||||||||
Medical condition: To evaluate the clinical benefit of sorafenib vs placebo as adjuvant treatment in subjects with HCC who received potentially curative treatment (surgical resection or local ablation). | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) GB (Completed) ES (Completed) AT (Completed) BE (Completed) FR (Completed) IT (Completed) PT (Completed) DE (Completed) GR (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003554-23 | Sponsor Protocol Number: NL68976.041.19 | Start Date*: 2021-12-03 | |||||||||||||||||||||
Sponsor Name:University Medical Center Utrecht | |||||||||||||||||||||||
Full Title: Sentinel lymph node detection in early-stage ORal Cavity squamous cell carcinoma using Magnetic Resonance (MR) lymphogrAphy | |||||||||||||||||||||||
Medical condition: The IMP will be used for the identification of sentinel lymph node(s) in patients with early-stage oral cavity squamous cell carcinoma and a clinically negative neck (T1-3, N0, M0). | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000927-29 | Sponsor Protocol Number: NL60405.100.17 | Start Date*: 2017-07-31 |
Sponsor Name:Catharina Ziekenhuis | ||
Full Title: Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a mult... | ||
Medical condition: Isolated unresectable colorectal peritoneal metastases | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003183-68 | Sponsor Protocol Number: PSMA-RGS | Start Date*: 2020-12-10 | |||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | |||||||||||||
Full Title: The Role of Imaging Guided Surgery to Improve the Detection of LymphNode metastases in Prostate Cancer Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection | |||||||||||||
Medical condition: Patients with prostate cancer (PCa) who are candidate to undergo surgical treatment with robot-assisted radical prostatectomy with a risk of lymph nodal invasion > 5% according to preoperative data | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
